But another underreported story of 2024 was the drastic drop we saw from EA’s prized battle royale, Apex Legends. Over 2024, Apex Legends showed the biggest drop in overall Steam concurrent ...

Apex Legends is still one of the best-feeling FPS games around, if you ask me, but that’s not stopped it from going through a major slump. Respawn has already revealed some radical changes that ...

Zimmer Biomet recently announced entering a definitive agreement to acquire all outstanding common shares of Paragon 28. Under the agreement, Zimmer Biomet will pay $13.00 per share, valuing ...

Zimmer Biomet to acquire Paragon 28 for $13/share, totaling $1.2B in enterprise value. Deal expected to close in H1 2025, with potential $1/share CVR based on 2026 sales milestones. Get real-time ...

Jan 28 (Reuters) - Zimmer Biomet (ZBH.N), opens new tab said on Tuesday it would acquire medical device company Paragon 28 (FNA.N), opens new tab for about $1.1 billion to expand its portfolio of ...

During the last three months, 5 analysts shared their evaluations of Paragon 28 FNA, revealing diverse outlooks from bullish to bearish. The table below offers a condensed view of their recent ...

Shares of FNA opened at $13.03 on Wednesday. Paragon 28 has a 1-year low of $4.65 and a 1-year high of $14.79. The company has a market capitalization of $1.09 billion, a P/E ratio of -17.60 and a ...

Zimmer Biomet Holdings (ZBH) and Paragon 28 (FNA) announced they have entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of common stock of Paragon 28 for an ...

Expected to Enhance Zimmer Biomet's Financial Profile; Immediately Accretive to Revenue Growth and Accretive to Adjusted EPS within 24 Months of Deal Close WARSAW, Ind. and ENGLEWOOD, Colo.

Paragon 28, Inc. FNA shares ended the last trading session 8.3% higher at $12.99. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

Paragon 28 shares rose 8.4% after Zimmer Biomet Holdings agreed to acquire the company. Shares were trading around $13.02. The stock is up about 2.6% over the last year. Zimmer, a medical ...

End-Markets, with Expansion into ~$5 Billion Foot and Ankle Segment Expected to Enhance Zimmer Biomet's financial Profile; Immediately Accretive to Revenue Growth and Accretive to Adjusted EPS ...